Company Filing History:
Years Active: 2004
Title: Ferenc Timár: Innovator in Angiogenesis Inhibition
Introduction
Ferenc Timár is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit angiogenesis. His work is crucial in the fight against tumor growth and metastasis.
Latest Patents
Timár holds a patent for "Heterocyclic compounds inhibiting angiogenesis." This invention relates to compounds of general formula (I), where R represents various groups, including alkyl and cycloalkyl groups. The compounds are designed to inhibit neovascularization in living tissues, making them valuable in preventing tumor growth and the formation of metastases. The patent highlights the potential of these compounds as active agents in pharmaceutical compositions.
Career Highlights
Ferenc Timár is associated with Ivax International GmbH, where he continues to advance his research and development efforts. His innovative approach to creating angiogenesis inhibitors has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Timár has collaborated with notable colleagues, including Nándor Makk and Gábor Ambrus. Their combined expertise has contributed to the advancement of research in the field of angiogenesis and cancer treatment.
Conclusion
Ferenc Timár's work in developing angiogenesis inhibitors represents a significant advancement in cancer treatment. His innovative compounds hold promise for improving therapeutic outcomes for patients facing tumor growth and metastasis.